Stocktoria
Vaxcyte, Inc. PCVX
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-06-12
Vaxcyte, Inc. statistics & valuation
Market cap$8.2B
P / B3.0×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -25.5% | -13.2% | -28.6% | -22.2% | -30.9% |
| Return on equity | -28.5% | -14.0% | -32.4% | -23.4% | -35.2% |
| Current ratio | 7.91 | 12.75 | 7.54 | 23.26 | 8.93 |
Source: SEC EDGAR filings · CIK 0001649094 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.